Non-small cell lung cancer

You have access
Implications of Preoperative Transbronchial Lung Biopsy for Non-small Cell Lung Cancer Less than 3-cm
MOTOAKI YASUKAWA, TAKESHI KAWAGUCHI, MICHITAKA KIMURA, TAKASHI TOJO and SHIGEKI TANIGUCHI

In Vivo March 2021, 35 (2) 1027-1031; DOI: https://doi.org/10.21873/invivo.12346
You have access
An Institutional Audit of Maximum Heart Dose in Patients Treated With Palliative Radiotherapy for Non-small Cell Lung Cancer
CARSTEN NIEDER and KRISTIAN S. IMINGEN

In Vivo March 2021, 35 (2) 955-958; DOI: https://doi.org/10.21873/invivo.12336
You have access
Weak-evidence Fusion Candidates Detected by a FusionPlex Assay Using the Ion Torrent System
SHIRO FUJITA, KATSUHIRO MASAGO, EIICHI SASAKI, SATOSHI TSUKUSHI, YOSHITSUGU HORIO, HIROAKI KURODA and TOYOAKI HIDA

In Vivo March 2021, 35 (2) 993-998; DOI: https://doi.org/10.21873/invivo.12342
You have access
Combining Nelfinavir With Chloroquine Inhibits In Vivo Growth of Human Lung Cancer Xenograft Tumors
JACLYN LOPICCOLO, SHIGERU KAWABATA, JOELL J. GILLS and PHILLIP A. DENNIS

In Vivo January 2021, 35 (1) 141-145; DOI: https://doi.org/10.21873/invivo.12241
You have access
Salvage Photon or Proton Radiotherapy for Oligo-recurrence in Regional Lymph Nodes After Surgery for Non-small Cell Lung Cancer
MASATOSHI NAKAMURA, KAYOKO OHNISHI, HITOSHI ISHIKAWA, KENSUKE NAKAZAWA, TOSHIHIRO SHIOZAWA, TOSHIYUKI OKUMURA, IKUO SEKINE, YUKIO SATO, NOBUYUKI HIZAWA and HIDEYUKI SAKURAI

In Vivo July 2020, 34 (4) 1883-1892; DOI: https://doi.org/10.21873/invivo.11984
You have access
Clinicopathological Features in Elderly ALK-rearranged Non-small Cell Lung Cancer Patients
KUNIHIKO MIYAZAKI, SHINYA SATO, TAKAHIDE KODAMA, TAKESHI NUMATA, TAKEO ENDO, YUSUKE YAMAMOTO, KEI SHIMIZU, HIDEYASU YAMADA, KENJI HAYASHIHARA, SHINICHIRO OKAUCHI, HIROAKI SATOH, YUTAKA YAMADA, TOMOHIRO TAMURA, KAZUTO SAITO, NORIHIRO KIKUCHI, KOICHI KURISHIMA, HIROICHI ISHIKAWA, HIROKO WATANABE, TOSHIHIRO SHIOZAWA, NOBUYUKI HIZAWA, YASUNORI FUNAYAMA, SHIGEN HAYASHI, HIROYUKI NAKAMURA and TAKAAKI YAMASHITA

In Vivo July 2020, 34 (4) 2001-2007; DOI: https://doi.org/10.21873/invivo.11998
You have access
High-dose Radiotherapy for Oligo-progressive NSCLC Receiving EGFR Tyrosine Kinase Inhibitors: Real World Data
MARIACARMELA SANTARPIA, GIUSEPPE ALTAVILLA, NICOLO BORSELLINO, ANDREA GIRLANDO, GIANFRANCO MANCUSO, STEFANO PERGOLIZZI, DARIO PIAZZA, ANTONIO PONTORIERO, MARIA ROSARIA VALERIO and VITTORIO GEBBIA

In Vivo July 2020, 34 (4) 2009-2014; DOI: https://doi.org/10.21873/invivo.11999
You have access
Serum CEA and CYFRA Levels in ALK-rearranged NSCLC Patients: Correlation With Distant Metastasis
TAKESHI NUMATA, TAKEO ENDO, HIDETOSHI YANAI, KYOKO OTA, YUSUKE YAMAMOTO, KEI SHIMIZU, HIDEYASU YAMADA, KENJI HAYASHIHARA, SHINICHIRO OKAUCHI, HIROAKI SATOH, YUTAKA YAMADA, TOMOHIRO TAMURA, KAZUTO SAITO, NORIHIRO KIKUCHI, KOICHI KURISHIMA, HIROICHI ISHIKAWA, HIROKO WATANABE, TOSHIHIRO SHIOZAWA, NOBUYUKI HIZAWA, YASUNORI FUNAYAMA, SHIGEN HAYASHI, HIROYUKI NAKAMURA and TAKAAKI YAMASHITA

In Vivo July 2020, 34 (4) 2095-2100; DOI: https://doi.org/10.21873/invivo.12013
You have access
Pleural Neutrophil-to-Lymphocyte Ratio May Be Associated With Early Disease Progression in Stage IV Non-small Cell Lung Cancer
JEONG UK LIM, CHANG DONG YEO, HYUNG WOO KIM, HYE SEON KANG, CHAN KWON PARK, JU SANG KIM, JIN WOO KIM, SEUNG JOON KIM and SANG HAAK LEE

In Vivo July 2020, 34 (4) 2179-2185; DOI: https://doi.org/10.21873/invivo.12027
You have access
Comparison of the Efficacy of EGFR Tyrosine Kinase Inhibitors Erlotinib and Low-dose Osimertinib on a PC-9-GFP EGFR Mutant Non-small-cell Lung Cancer Growing in the Brain of Nude Mice
YUKI KATSUYA, KENTARO MIYAKE, TAKASHI HIGUCHI, HIROMICHI OSHIRO, NORIHIKO SUGISAWA, SHREE RAM SINGH, YASUSHI GOTO, MING ZHAO and ROBERT M. HOFFMAN

In Vivo May 2020, 34 (3) 1027-1030; DOI: https://doi.org/10.21873/invivo.11871

Main menu

User menu

Search

Non-small cell lung cancer

Pages